FdaApplication

ANDA 216193

Back to search

Identifiers

Properties

PropertyValue
applicant_nameAJANTA PHARMA LTD
application_typeANDA
approval_date2023-03-24

Products (3)

ProductActive ingredientStrengthDosage form
CARBAMAZEPINECARBAMAZEPINE100MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE400MGTABLET, EXTENDED RELEASE;ORAL
CARBAMAZEPINECARBAMAZEPINE200MGTABLET, EXTENDED RELEASE;ORAL

3 products